Matches in Wikidata for { <http://www.wikidata.org/entity/Q85236284> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q85236284 description "artículu científicu espublizáu en xunetu de 2015" @default.
- Q85236284 description "scientific article published on 07 July 2015" @default.
- Q85236284 description "wetenschappelijk artikel" @default.
- Q85236284 description "наукова стаття, опублікована в липні 2015" @default.
- Q85236284 name "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 name "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 type Item @default.
- Q85236284 label "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 label "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 prefLabel "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 prefLabel "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 P1433 Q85236284-EC04C87F-1E77-4B9F-84CF-A630DE4C12CF @default.
- Q85236284 P1476 Q85236284-F7A662C2-C9D3-4CCC-8CB4-16F4AE575E5C @default.
- Q85236284 P2093 Q85236284-1ADBDCF0-1F31-4FF4-AECC-6AAE04A47B31 @default.
- Q85236284 P2093 Q85236284-29537866-0BFB-4611-82DE-8563B2C8DC90 @default.
- Q85236284 P2093 Q85236284-4A539DB9-30B6-4843-8D5A-F4E5AC2B07CC @default.
- Q85236284 P2093 Q85236284-60C56054-5B68-41C7-ACE5-A14D8AF94AC4 @default.
- Q85236284 P2093 Q85236284-7C60AB19-1ED7-4A0E-B469-6C0F98D09F1F @default.
- Q85236284 P2093 Q85236284-974DA63B-999B-4C34-AF1A-0AA18B07C1F3 @default.
- Q85236284 P2093 Q85236284-B3494102-DB23-4420-94CB-D3264A841832 @default.
- Q85236284 P2093 Q85236284-C43FC7AF-D02C-4411-9FCC-5562F59137A1 @default.
- Q85236284 P2093 Q85236284-D725A517-FCF4-4335-9790-83890DA49550 @default.
- Q85236284 P304 Q85236284-42788FCE-D593-4110-861D-9D5E2E0143C8 @default.
- Q85236284 P31 Q85236284-402F1644-410A-4965-B169-DA75E98616DE @default.
- Q85236284 P356 Q85236284-2DC9CE2C-60B8-494B-9FB8-894B9FF1BAAB @default.
- Q85236284 P433 Q85236284-3A054706-98AD-47BC-8995-DA77F0999C23 @default.
- Q85236284 P478 Q85236284-860004E0-759F-40E8-BAD5-C0C6C7EF1D9C @default.
- Q85236284 P577 Q85236284-D81FF8E7-065D-47A6-B093-44C5CB58BEFF @default.
- Q85236284 P698 Q85236284-8AC65A05-37E6-4812-BF89-09D68D48DB68 @default.
- Q85236284 P921 Q85236284-403CE21A-AC51-4C42-A8DE-BA8C1406D476 @default.
- Q85236284 P921 Q85236284-C5368C01-83C3-40DC-9AFD-76B511660E4E @default.
- Q85236284 P921 Q85236284-E950E9B5-63FB-4B2F-9D9B-83FBC3EAA189 @default.
- Q85236284 P356 10428194.2015.1055481 @default.
- Q85236284 P698 26022523 @default.
- Q85236284 P1433 Q6534493 @default.
- Q85236284 P1476 "Lack of clinical benefit of zoledronic acid in myelofibrosis: results of a prospective multi-center phase II trial" @default.
- Q85236284 P2093 "Andreas Gunther" @default.
- Q85236284 P2093 "Ignacio Español" @default.
- Q85236284 P2093 "Jacob Rowe" @default.
- Q85236284 P2093 "Jolien Raddoux" @default.
- Q85236284 P2093 "Marc Boogaerts" @default.
- Q85236284 P2093 "Martin Gramatzki" @default.
- Q85236284 P2093 "Michel Delforge" @default.
- Q85236284 P2093 "Simon T Durrant" @default.
- Q85236284 P2093 "Timothy Devos" @default.
- Q85236284 P304 "470-473" @default.
- Q85236284 P31 Q13442814 @default.
- Q85236284 P356 "10.3109/10428194.2015.1055481" @default.
- Q85236284 P433 "2" @default.
- Q85236284 P478 "57" @default.
- Q85236284 P577 "2015-07-07T00:00:00Z" @default.
- Q85236284 P698 "26022523" @default.
- Q85236284 P921 Q1752571 @default.
- Q85236284 P921 Q218507 @default.
- Q85236284 P921 Q42824440 @default.